(ZLAB) Zai Lab - Performance 100.9% in 12m
ZLAB performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-35.62%
#54 in Peer-Group
Rel. Strength
93.75%
#465 in Stock-Universe
Total Return 12m
100.93%
#14 in Peer-Group
Total Return 5y
-57.91%
#71 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 43.03 USD |
| 52 Week Low | 16.25 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 37.43 |
| Buy/Sell Signal +-5 | -1.64 |
| Support / Resistance | Levels |
|---|---|
| Support | 33.5, 30.8, 26.9, 24.4, 20.0, 18.0 |
| Resistance |
12m Total Return: ZLAB (100.9%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
0.31% | 66.4% | 81.3% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-11.3% | -10.9% | 137% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-2.26% | -8.02% | 39.9% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
2.47% | 33.7% | 4.38% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
1.42% | -10.5% | -0.06% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.2% | 64.2% | 3.4% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
1.94% | 59.9% | -1.58% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.88% | 35.5% | 16% | 28.9 | 15.1 | 0.63 | -62.1% | -19.3% |
Performance Comparison: ZLAB vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ZLAB
| Total Return (including Dividends) | ZLAB | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 10.95% | 3.18% | 4.52% |
| 3 Months | -3.87% | 2.36% | 10.25% |
| 12 Months | 100.93% | -10.75% | 14.16% |
| 5 Years | -57.91% | -24.51% | 116.91% |
| Trend Score (consistency of price movement) | ZLAB | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 6.8% | 18.8% | 79.2% |
| 3 Months | 49.7% | 71.5% | 92.9% |
| 12 Months | 84.8% | -84.3% | 44.2% |
| 5 Years | -81.1% | -52.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th74.50 | 7.54% | 6.15% |
| 3 Month | %th45.50 | -6.09% | -12.81% |
| 12 Month | %th94.00 | 125.13% | 76.00% |
| 5 Years | %th66.00 | -44.24% | -80.59% |
FAQs
Does Zai Lab (ZLAB) outperform the market?
Yes,
over the last 12 months ZLAB made 100.93%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.75%.
Over the last 3 months ZLAB made -3.87%, while XBI made 2.36%.
Performance Comparison ZLAB vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ZLAB vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -6% | 6.4% | 26.1% | 87% |
| US NASDAQ 100 | QQQ | -6.6% | 5.4% | 24.7% | 87% |
| German DAX 40 | DAX | -6.8% | 10.6% | 10.9% | 70% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -5.3% | 8.4% | 30.1% | 84% |
| Hongkong Hang Seng | HSI | -6.3% | 4.1% | 8.9% | 65% |
| India NIFTY 50 | INDA | -6.4% | 8.6% | 25.1% | 101% |
| Brasil Bovespa | EWZ | -5.3% | 7.5% | 4.5% | 90% |
ZLAB vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -7.2% | 4.1% | 19.8% | 73% |
| Consumer Discretionary | XLY | -5.5% | 9.1% | 34.1% | 80% |
| Consumer Staples | XLP | -2.5% | 12.2% | 27.2% | 92% |
| Energy | XLE | -2.7% | 6.4% | 28.7% | 104% |
| Financial | XLF | -5.7% | 8.5% | 22.9% | 73% |
| Health Care | XLV | -4.9% | 9.3% | 32.8% | 107% |
| Industrial | XLI | -5.6% | 7.8% | 19.3% | 77% |
| Materials | XLB | -4.6% | 8.6% | 25.3% | 98% |
| Real Estate | XLRE | -1.3% | 11.4% | 27.8% | 89% |
| Technology | XLK | -6.8% | 2.5% | 23.9% | 90% |
| Utilities | XLU | -3.6% | 10% | 22.4% | 77% |
| Aerospace & Defense | XAR | -7.9% | 1.3% | 5% | 49% |
| Biotech | XBI | -4.4% | 7.8% | 38.9% | 112% |
| Homebuilder | XHB | -4.6% | 7.1% | 36.6% | 100% |
| Retail | XRT | -3.8% | 8.8% | 33.5% | 94% |
ZLAB vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 0.6% | 1.89% | 33.3% | 111% |
| Natural Gas | UNG | -1.8% | 7.5% | 39.5% | 101% |
| Gold | GLD | -0.4% | 12.4% | 6.1% | 61% |
| Silver | SLV | -2.5% | 3.3% | 7.8% | 79% |
| Copper | CPER | -6.9% | 2.3% | 7.7% | 86% |
ZLAB vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -4.2% | 9.1% | 29.9% | 100% |
| iShares High Yield Corp. Bond | HYG | -4% | 9.4% | 26.6% | 90% |